series-b
Stage
2018
Founded
2
Investors
About
Oxolife is a clinical-stage biotech company developing novel therapies for women's health. Their primary focus is on improving embryo implantation in in-vitro fertilization (IVF) treatments.
Explore Oxolife's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.